TAK-003: development of a tetravalent dengue vaccine
Introduction Dengue incidence has increased over the past few decades. One tetravalent dengue vaccine based on a yellow fever backbone has been approved, but due to increased risk of severe disease in dengue-naïve recipients, its use is limited to individuals with prior dengue exposure.Areas covered...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2025-12-01
|
| Col·lecció: | Expert Review of Vaccines |
| Matèries: | |
| Accés en línia: | https://www.tandfonline.com/doi/10.1080/14760584.2025.2490295 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|